110 related articles for article (PubMed ID: 6195483)
1. Antihypertensive effect of prizidilol.
Andrén L; Hansson L; Svensson A
J Cardiovasc Pharmacol; 1983; 5(5):898-900. PubMed ID: 6195483
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
[TBL] [Abstract][Full Text] [Related]
3. Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.
Karlberg BE; Larsson R; Ohman KP; Norlander B; Wirsen A; Hed J; Lundh BL; Flock A
Eur J Clin Pharmacol; 1983; 25(2):179-86. PubMed ID: 6138257
[TBL] [Abstract][Full Text] [Related]
4. Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension.
Larsson R; Karlberg BE; Norlander B; Wirsén A
Clin Pharmacol Ther; 1981 May; 29(5):588-93. PubMed ID: 6111409
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology and pharmacokinetics of prizidilol in hypertensive patients.
Chaignon M; Decourt S; Guelpa G; Rocher I; Flouvat B; Guédon J
J Cardiovasc Pharmacol; 1983; 5(6):1068-73. PubMed ID: 6196556
[TBL] [Abstract][Full Text] [Related]
6. Prizidilol (SKF 92657) in primary hypertension.
Karlberg BE; Larsson R; Ohman KP
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():461s-464s. PubMed ID: 7188585
[TBL] [Abstract][Full Text] [Related]
7. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A
Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
[TBL] [Abstract][Full Text] [Related]
8. Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.
Lüscher T; Havelka J; Greminger P; Tuma J; Täuber M; Siegenthaler W; Vetter W
Eur J Clin Pharmacol; 1982; 23(5):411-5. PubMed ID: 6129980
[TBL] [Abstract][Full Text] [Related]
9. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
Andersen GS; Hartling OJ; Hein HO; Leth A
Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular response to exercise and regional haemodynamics during treatment with prizidilol hydrochloride (SK & F 92 657) in moderately severe essential hypertension.
Andersson O; Ljungman S; Berglund G
Eur J Clin Pharmacol; 1983; 25(5):577-80. PubMed ID: 6662157
[TBL] [Abstract][Full Text] [Related]
13. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
Steiner JA; Clancy A; Manghani KK; James IM
Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
[TBL] [Abstract][Full Text] [Related]
14. Effects of prizidilol (SKF 92657) on blood pressure, haemodynamics, sympathetic nervous system activity and plasma volume in essential hypertension.
Fariello R; Alicandri CL; Agabiti-Rosei E; Romanelli G; Castellano M; Beschi M; Platto L; Di Priolo SL; Muiesan G
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():465s-468s. PubMed ID: 7318352
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657).
Costa FV; Borghi C; Boschi S; Ambrosioni E
Int J Clin Pharmacol Res; 1984; 4(5):373-9. PubMed ID: 6151553
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effect of prizidilol.
Jounela AJ; Honkala M; Huikuri H
Ann Clin Res; 1984; 16(3):176-80. PubMed ID: 6383185
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
Edmondstone WM; Waller JF; Manghani KK; Hill PL; Bell AJ; Denison DM
Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
[TBL] [Abstract][Full Text] [Related]
19. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
Pitcher DW; Curry PV; Trounce JR
Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
